Literature DB >> 23726463

Identification and epidemiological relatedness of clinical Elizabethkingia meningoseptica isolates from central Taiwan.

Yi-Cheng Chang1, Hsueh-Hsia Lo2, Hsiu-Ying Hsieh3, Shan-Min Chang4.   

Abstract

BACKGROUND: Elizabethkingia meningoseptica is an opportunistic pathogen. Identification of E. meningoseptica based on conventional methods is rather labor- and time-consuming. The information on epidemiological relatedness and microbiological characteristics of E. meningoseptica isolates from central Taiwan was limited.
METHODS: Forty E. meningoseptica isolates identified by conventional methods were collected by the Central Laboratory of Central Region Hospital Alliance between 2007 and 2011. The amplification of 16S ribosomalDNA gene by polymerase chain reaction with species-specific or universal primers following DNA sequencing was used as a standard identification method. The feasibility of Vitek 2 GN card was also evaluated. Some clinical information of the patients and the drug susceptibilities and epidemiological relatedness of the isolates were analyzed.
RESULTS: For the 40 isolates, 39 E. meningoseptica and one Chryseobacterium indologenes were identified using 16S rDNA sequencing. Among the 39 isolates, all could be identified using species-specific primers, whereas only 84.6% could be identified by Vitek 2 GN card with excellent discrimination. All E. meningoseptica isolates were susceptible to minocycline but resistant to many drugs examined including ceftazidime, amikacin, colistin, and imipenem. The pulsed field gel electrophoresis (PFGE) patterns demonstrated that most isolates were quite genetic diversity. The patients had average age of 72.2 ± 14.5 years old (excluded one child patient of 1 year old) and 79.5% of patients were male. Twenty-three patients (59.0%) had underlying diseases.
CONCLUSION: The designed species-specific primers could be used to identify E. meningoseptica with 100% of specificity and sensitivity, whereas the Vitek 2 GN card showed considerable ability in E. meningoseptica identification. The PFGE patterns showed that most isolates were genetic diversity enough to exclude the possibility of intrahospital spread.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Central Taiwan; Elizabethkingia meningoseptica; Epidemiological relatedness; Identification

Mesh:

Substances:

Year:  2013        PMID: 23726463     DOI: 10.1016/j.jmii.2013.03.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  Challenges in the identification of Chryseobacterium indologenes and Elizabethkingia meningoseptica in cases of nosocomial infections and patients with cystic fibrosis.

Authors:  É B de Carvalho Filho; F A L Marson; C E Levy
Journal:  New Microbes New Infect       Date:  2017-09-13

2.  Isolation and Characterization of a New Phage Infecting Elizabethkingia anophelis and Evaluation of Its Therapeutic Efficacy in vitro and in vivo.

Authors:  Shih-Yi Peng; Li-Kuang Chen; Wen-Jui Wu; Prajna Paramita; Po-Wei Yang; Yun-Zhong Li; Meng-Jiun Lai; Kai-Chih Chang
Journal:  Front Microbiol       Date:  2020-05-13       Impact factor: 5.640

3.  Multicentre MDR Elizabethkingia anophelis isolates: Novel random amplified polymorphic DNA with capillary electrophoresis systems to rapid molecular typing compared to genomic epidemiology analysis.

Authors:  Ming-Jr Jian; Cherng-Lih Perng; Jun-Ren Sun; Yun-Hsiang Cheng; Hsing-Yi Chung; Yu-Hsuan Cheng; Shih-Yi Lee; Shu-Chen Kuo; Hung-Sheng Shang
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

4.  Comparative genomic analyses reveal diverse virulence factors and antimicrobial resistance mechanisms in clinical Elizabethkingia meningoseptica strains.

Authors:  Shicheng Chen; Marty Soehnlen; Jochen Blom; Nicolas Terrapon; Bernard Henrissat; Edward D Walker
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

5.  Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China.

Authors:  Yajuan Li; Tingting Liu; Cuixiao Shi; Bo Wang; Tingting Li; Ying Huang; Yuanhong Xu; Ling Tang
Journal:  Front Public Health       Date:  2022-09-20

6.  Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in Elizabethkingia species.

Authors:  Ming-Jr Jian; Yun-Hsiang Cheng; Cherng-Lih Perng; Hung-Sheng Shang
Journal:  PeerJ       Date:  2018-09-12       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.